Clinical Trial Update: Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386) [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in participants with renal insufficiency, with and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Midazolam (Midazolam)
• Pitavastatin (Pitavastatin)
• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2020-01-09